MADISON,
Wis., Feb. 5, 2024 /PRNewswire/ -- Accuray
Incorporated (NASDAQ: ARAY) announced today its participation
in the BTIG MedTech, Digital Health, Life Science & Diagnostic
Tools Conference, which takes place on February 13, 2024.
BTIG-hosted events are intended for prospective and existing
BTIG clients only. To request a one-on-one meeting with management,
please contact your BTIG representative with interest.
About Accuray
Accuray is committed to expanding the powerful potential of
radiation therapy to improve as many lives as possible. We invent
unique, market-changing solutions that are designed to deliver
radiation treatments for even the most complex cases—while making
commonly treatable cases even easier—to meet the full spectrum of
patient needs. We are dedicated to continuous innovation in
radiation therapy for oncology, neuro-radiosurgery, and
beyond, as we partner with clinicians and administrators,
empowering them to help patients get back to their lives, faster.
Accuray is headquartered in Madison,
Wisconsin, with facilities worldwide. To learn more, visit
www.accuray.com or follow us on Facebook, LinkedIn, X,
and YouTube.
Investor Contact
Aman Patel, CFA
Investor Relations, ICR-Westwicke
+1 (443) 450-4191
aman.patel@westwicke.com
Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/accuray-to-participate-in-the-btig-medtech-digital-health-life-science--diagnostic-tools-conference-302053822.html
SOURCE Accuray Incorporated